To investigate how perturbations in various lipid metabolic pathways influence the STING immune pathway.
Approach:
Targeted Small Molecule Screen: Conducted across multiple lipid metabolic pathways, including mevalonate, PPAR (fatty acid), and arachidonic acid pathways.
Key Findings:
Positive and negative perturbations of enzymes in lipid pathways significantly modulate STING-dependent signal transduction.
Identified metabolic nodes linking lipid homeostasis with innate immune signaling.
Existing lipid-lowering and metabolic therapies may have immunomodulatory effects on STING.
Interpretation:
STING integrates information about lipid metabolism into immune responses.
Limitations:
The study primarily focuses on specific lipid pathways and may not encompass all lipid metabolic influences on STING.
Further research is needed to clarify the mechanisms by which STING senses lipid metabolic changes.
Conclusion:
Understanding the STING-lipid metabolic interface could open new avenues for therapeutic interventions in immune-related diseases.
